BioAdaptives

BioAdaptives Revenue per Employee

The Revenue per Employee of BioAdaptives (BDPT) as of Nov 1, 2026 is 18,278.00 USD. In the previous year, Revenue per Employee was 12,669.00 USD — a change of 44.27% (higher).

Revenue per Employee

18,278.00USD

YoY

44.27%

Last updated:

Revenue per Employee of BioAdaptives is 2025 18,278.00 USD. Revenue per Employee of BioAdaptives was 2024 12,669.00 USD. It decreases by 44.27% higher compared to the previous year.

The BioAdaptives Revenue per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Employee
Date
Revenue per Employee
Jan 1, 2016
19,044.00 USD
Jan 1, 2019
9,934.00 USD
Jan 1, 2020
16,327.00 USD
Jan 1, 2021
19,776.00 USD
Jan 1, 2022
17,176.00 USD
Jan 1, 2023
28,565.00 USD
Jan 1, 2024
12,669.00 USD
Jan 1, 2025
18,278.00 USD
The BioAdaptives Revenue per Employee history
YEARRevenue per EmployeeYoY
18,278.00USD+44.27%
12,669.00USD-55.65%
28,565.00USD+66.31%
17,176.00USD-13.15%
19,776.00USD+21.12%
16,327.00USD+64.35%
9,934.00USD-47.84%
19,044.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

BioAdaptives Stock analysis

What does BioAdaptives do? BioAdaptives, Inc. generates revenue through the sale of health and wellness products including dietary supplements, specialty food items, and devices that optimize bioelectromagnetic availability. The company markets PrimiCell and PrimiLive under a product agreement with Ferris Holding, Inc., targeting consumers seeking cognitive enhancement, fatigue reduction, and anti-aging solutions. PrimiTrim serves the weight control segment, while Equine Regen and Equine Regen Plus are in advanced testing for veterinary use. The firm also develops a dog product, expanding its wellness offerings across human and animal health markets. Ferris Holding, Inc. provides the intellectual property and products that BioAdaptives markets, including PrimiCell and PrimiLive, which are positioned for cognition, focus, and emotional wellness. The company's advanced-stage products Equine Regen and Equine Regen Plus cater to the veterinary segment, with PrimiTrim addressing weight management needs. BioAdaptives' product portfolio spans nutraceuticals, devices, and specialty foods designed to improve physical and emotional wellness across multiple consumer segments. BioAdaptives focuses on selling devices and nutraceuticals that target cognitive performance, fatigue reduction, and anti-aging, with PrimiCell and PrimiLive as key products under the Ferris agreement. The company's weight control solution PrimiTrim appeals to consumers seeking wellness through diet, while Equine Regen and Equine Regen Plus target animal health providers. The firm's development of a dog product further diversifies its offerings in the wellness market. BioAdaptives is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioAdaptives stock

Revenue per Employee of BioAdaptives is 18,278.00 USD in 2025.

Revenue per Employee of BioAdaptives changed from 12,669.00 USD to 18,278.00 USD, representing a 44.27% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Employee BioAdaptives since 2006 – with annual values, charts, and detailed analysis.

Revenue per employee measures workforce productivity by dividing total revenue by the number of employees. Higher values indicate more efficient operations.

Revenue per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Revenue per Employee's BioAdaptives historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — BioAdaptives

All Key Metrics — BioAdaptives